Evidence map›Paper›PMID 39134636›Full record

ArticleCommunications biology2024

Predicting monoclonal antibody binding sequences from a sparse sampling of all possible sequences.

Pritha Bisarad, Laimonas Kelbauskas, Akanksha Singh, Alexander T Taguchi, Olgica Trenchevska, Neal W Woodbury

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pritha Bisarad *School of Molecular Sciences, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-2677-9847
Laimonas Kelbauskas *Center for Molecular Design and Biomimetics, Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Akanksha Singh *School of Molecular Sciences, Arizona State University, Tempe, AZ, USA.ORCID 0000-0002-8176-0129
Alexander T TaguchiiBio Inc., San Diego, CA, USA.ORCID 0000-0002-5940-5948
Olgica TrenchevskaCowper Sciences Inc., Chandler, AZ, USA.
Neal W WoodburySchool of Molecular Sciences, Arizona State University, Tempe, AZ, USA. nwoodbury@asu.edu.ORCID 0000-0002-9718-0209

Funding

Arizona State University (ASU) NA
6 · The paper itself

Abstract

Previous work has shown that binding of target proteins to a sparse, unbiased sample of all possible peptide sequences is sufficient to train a machine learning model that can then predict, with statistically high accuracy, target binding to any possible peptide sequence of similar length. Here, highly sequence-specific molecular recognition is explored by measuring binding of 8 monoclonal antibodies (mAbs) with specific linear cognate epitopes to an array containing 121,715 near-random sequences about 10 residues in length. Network models trained on resulting sequence-binding values are used to predict the binding of each mAb to its cognate sequence and to an in silico generated one million random sequences. The model always ranks the binding of the cognate sequence in the top 100 sequences, and for 6 of the 8 mAbs, the cognate sequence ranks in the top ten. Practically, this approach has potential utility in selecting highly specific mAbs for therapeutics or diagnostics. More fundamentally, this demonstrates that very sparse random sampling of a large amino acid sequence spaces is sufficient to generate comprehensive models predictive of highly specific molecular recognition.

Indexed as

Antibodies, MonoclonalAmino Acid SequenceBinding Sites, AntibodyComputer SimulationEpitopesHumansMachine LearningProtein BindingAntibodies, MonoclonalEpitopes

Identifiers

PMID39134636
PMCPMC11319732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.